Spontaneous Bacterial Peritonitis

Slides:



Advertisements
Similar presentations
Learning objectives To understand the pathophysiologic basis for vasoactive therapies for HRS To become familiar with the diagnostic criteria for HRS To.
Advertisements

Risё Stribling, MD Medical Director of Liver Transplant St Luke’s Medical Center Associate Professor of Surgery Baylor College of Medicine.
MAZEN HASSANAIN PORTAL HYPERTENSION. CAUSES Cirrhosis Non-cirrhosis.
Body Fluids and Infectious Complications. Body Fluids Intracellular Extracellular Plasma (fluid component of blood) Interstitial fluid (surrounds the.
Management of ascites in patients with cirrhosis Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Antibiotic treatment choices for SBP Treviso 8 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Approach to peritoneal fluid analysis Dr Yasir M Khayyat Assistant Professor,Consultant Gastroenterologist Umm AlQura University.
Management of Clostridium difficile Infections
Fatal cirrhosis decompensation due to brucellosis: therapeutic issues. Maria Kosmidou, 1 Leonidas Christou 1 Markos Marangos, 2 Georgios Panos, 2 Epameinondas.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Core Topic UCI Internal Medicine Residency Learning Objectives Review the major causes of upper GI bleeding and important elements of the history.
Cirrhosis of Liver: Continuation Nursing 2015 Part two 22 to 42slides.
HEPATO renal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine.
Hepatorenal Syndrome Dr Allister J Grant Leicester Liver Unit
Creatinine (mg/dL) MonthsWeeks Therapeutic paracentesis Cefotaxime Type-2 HRSType-1 HRS Encephalopathy Jaundice CLINICAL TYPES.
Patient presenting with altered mental status
Chronic Liver Disease. Burden Markedly decreased life expectancy 12th leading cause of death in US 25,000 deaths annually in US High morbidity and mortality.
Patient # 3 = Lab Results Your Results: Head CT: Normal LP:
Patient # 1 = Lab Results Your Results: –CBC: WBC 22 (normal /ul) –BMP: WNL Urine Pregnancy: Neg Head CT: Neg LP: –Cloudy fluid –Opening pressure:
Spontaneous Bacterial Peritonitis Katherine Yu May 2014.
Complications of liver cirrhosis
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Complications of Liver Cirrhosis
*Transudate (
Ascites and Spontaneous Bacterial Peritonitis Arthur Harris, MD Attending, Division of Gastroenterology Jacobi Medical Center/North Central Bronx Hospital.
Journal Club – Hepa Visite Catharina Zeuzem
Spontaneous bacterial peritonitis (SBP)
Alcoholic Hepatitis Miriam Nojan PGY-2 April 2016.
Ascites 소화기내과 F1 김경엽.  Ascites: pathologic accumulation of fluid in the peritoneal cavity Causes of ascitesPercentage Cirrhosis81 % Cancer10 % Heart.
Clinicaloptions.com/hepatitis HALT-C: Long-term Maintenance Peginterferon alfa-2a Slideset on: Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis.
Complications of liver cirrhosis. Recognize the major complications of cirrhosis. Understand the pathological mechanisms underlying the occurrence of.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
INTERNAL MEDICINE BENJAMIN YIP 4/13/16 Mini Lecture: Hepatorenal Syndrome.
CIRRHOSIS MANAGEMENT FOR HOSPITALISTS Madhav Devani 6/7/16.
Number Needed to Treat Alex Djuricich, MD Indiana University School of Medicine Department of Medicine Ambulatory Rotation
Fungal Peritonitis (FP) Constantinos J. Stefanidis “P. and A. Kyriakou” Children’s Hospital Athens, Greece.
Intern Report Patient Presentation  55yM no PMH presenting with worsening abdominal pain for 2-3 days. Describes pain as diffuse, non-radiation,
Approach to Ascites Updated by Daniel Kim, 06/2017.
Raymond A Rubin, MD 5 March 2015
Yadegarynia, D. MD..
Liver Disease tutoring Part 1
Oral Vancomycin Effect in Primary Sclerosing Cholangitis
Nutrition for Hepatic Disease
Liver Disease tutoring Part 2
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
Therapeutics 4 tutoring 3/21/17
hospitalized with spontaneous bacterial peritonitis
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
ASCITES By Dr WAQAR MBBS, MRCP Asst. Professor Maarefa College.
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Multiple factors can predispose to decompensation in a patient with cirrhosis. Risk factors for decompensation include: Bleeding Infection Alcohol.
COMPLICATIONS OF CIRRHOSIS
Fluid Analysis.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Intra-Abdominal Candidiasis, Candida peritonitis
Management of Clostridium Difficile Infection
Alcoholic hepatitis with diffuse interstitial fibrosis
Emergency Quick Assessment
R Moreau, L Elkrief, C Bureau et al. Gastroenterology. Aug [Epub]
Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression  Gati A. Goel, Abhishek Deshpande,
Alcoholic Hepatitis (1)
Internal medicine L-4 Liver cirrhosis & portal hypertension
CLINICAL PROBLEM SOLVING
Cirrhosis with ascites-consider pt for liver transplant
Volume 146, Issue 7, Pages e1 (June 2014)
CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF ASCITES, SBP AND HRS
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Spontaneous Bacterial Peritonitis James Han May 2018

Objectives Learn to diagnose spontaneous bacterial peritonitis (SBP) Learn how to treat SBP Know the indications for the primary prophylaxis of SBP and the treatment regimen

Diagnosis Diagnosed by performing paracentesis of ascites fluid Do the paracentesis BEFORE antibiotics as ascites fluid sterilizes quickly (86% chance of negative culture 6 hours after antibiotic use [3]) Early recognition of need for paracentesis is key! Each hour of delay in paracentesis leads to a 3.3% increase in mortality! (1) Send ascites fluid for Cell count Gram stain Culture In addition to ascites cell count of ≥ 250 PMNs AND a positive culture, secondary causes of peritonitis should be excluded. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis.AUAkriviadis EA, Runyon BA SOGastroenterology. 1990;98(1):127. 

Diagnosis Diagnostic criteria ascites PMN cell count of ≥ 250 PMNs/mm3 positive ascites culture secondary causes of bacterial peritonitis ruled out ALL PATIENTS WITH PMN >250 SHOULD BE STARTED ON ANTIBIOTICS EMPIRICALLY WHILE WAITING FOR CULTURES How to calculate the number of PMNs in ascitic fluid: Ascitic fluid cell count multiplied by the percentage of PMNs Example: Ascitic fluid cell count is 1,000 and there are 30% PMNs -> The number of PMNs is 1,000 x 0.3 = 300 Causes of secondary peritonitis include traumatic ascites, bowel perforation, iatrogenic causes. Suspect secondary causes of peritonitis when ascites Total protein >1g/dl Glucose <50mg/dl LDH> upper limit of normal for serum The ascites culture for SBP is usually polymicrobial. Microbiology: 70% GNR (E. coli, Klebsiella), 30% GPC (enterococcus, S. pneumo), nosocomial (fungi, pseudomonas) There are different types of ascites which can be characterized by the ascites cell count and culture. There is culture-negative neutrocytic ascites (CNNA) with ≥ 250 PMNs but a negative culture. Clinically and prognostically like SBP; need to look for TB, carcinomatosis, pancreatitis. There is non-neutrocytic bacterascites (NNBA) with <250 PMNs, but a positive culture (usually one organism). This acts like SBP (may be early SBP) when there are symptoms; without symptoms has better prognosis, but need to re-tap. Correction needed if traumatic paracentesis occurs as it can lead to erroneous PMN count True PMN = absolute PMN – (absolute RBC/250)

Treatment Inpatient treatment 3rd generation cephalosporin – typically ceftriaxone at 2g IV daily x 5 days Stop non-selective beta blockers (typically propranolol or carvedilol) – associated with worse outcomes [4] Outpatient treatment – for uncomplicated SBP only. Ciprofloxacin 500mg BID x 5 days Avoid if patient has been on oral FQNs for prophylaxis Treatment is Cefotaxime 2 gm IV q8 hours for 5 days. Oral fluoroquinolone treatment may be indicated in ambulatory patients with stable hepatic and kidney function, and no evidence of encephalopathy. Use of concurrent IV albumin at 1.5 g/kg on admission and 1 g/kg on day 3 has been shown to decrease in-hospital mortality by 20% in patients with serum creatinine values of 1.5 mg/dL or greater. Patients with advanced liver disease, including those with a serum total bilirubin of 4 or greater, also benefit from IV albumin to prevent kidney failure associated with SBP. Uncomplicated SBP = stable renal and hepatic function and no encephalopathy OR asymptomatic Nonselectiveβblockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.AUMandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M, Hagmann M, Blacky A, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Reiberger T SOGastroenterology. 2014;146(7):1680. Epub 2014 Mar 12. 

Treatment The addition of IV albumin 1.5 g/kg at the time of diagnosis and 1 g/kg on day three may increase survival and reduce the rate of renal impairment if the patient has the following Creatinine >1 mg/dL BUN >30 mg/dL Total bilirubin >4 mg/DL If patient is not improving, consider repeat paracentesis at 48 hours If secondary peritonitis is suspected or polymicrobial peritonitis is present Add metronidazole

Prophylaxis Benefits of prophylaxis: Indication Regimen 1 Regimen 2 Ascitic fluid total protein < 1g/dL Ciprofloxacin 500mg daily Bactrim DS daily Prior History of SBP Gastrointestinal Hemorrhage Ceftriaxone 1g IV, then ciprofloxacin 500mg BID x 5 days Ciprofloxacin 500mg BID x 5 days Benefits of prophylaxis: Improves 1 year survival probability Reduces 1 year probability of SBP Minimize use of PPIs (associated with increased risk of SBP) [5] Regimen 1 for GI hemorrhage prophylaxis is for Childs Pugh class B, regimen 2 is for Childs Pugh class A Benefits of ppx: Improved 1 year survival probability from 48% to 60% Reduces 1 year probability of SBP from 61% to 7% Fernandez J, Navasa M, Planas R, et al. Primary prophylaxis of SBP delays hepatorenal syndrome and imporves survival in cirrhosis. Gastroenterology 2007; 133:818-24. 5) Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.AUGoel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD SOClin Gastroenterol Hepatol. 2012;10(4):422. Epub 2011 Dec 7.

Case Study A 45 year old man is admitted to the hospital for a two day history of fever and abdominal pain. His medical history is notable for cirrhosis due to chronic hepatitis C, esophageal varices, ascites, and minimal hepatic encephalopathy. He has ascites on exam. Labs: WBC 3.5, Hgb 10, Plt 70. Cr 1.8. Total bilirubin 4. ALT 30, AST 40. Diagnostic paracentesis discloses a cell count of 2,000/microliter with 20% neutrophils, a total protein level 0.8 g/dL, and an albumin of 0.6 g/dL. Ascitic fluid culture is positive. What is his diagnosis? What is the most appropriate treatment? Should he be on prophylaxis and if so, what kind? Diagnosis: He has spontaneous bacterial peritonitis. The diagnosis is made in the setting of a positive ascitic fluid bacteria culture and elevated ascitic fluid absolute PMN cell count (>=250/microliter) without e/o secondary causes of peritonitis. Treatment: cefotaxime 2 gm IV q8 hours for 5 days plus albumin. The use of cefotaxime plus albumin at 1.5 g/kg on admission and 1g/kg on day 3 has been shown to decrease in-hospital mortality by 20% of patient with serum Cr >= 1.5, as in this patient. Remember, patients with advanced liver disease, including those with total bilirubin of >=4, as in this patient, also benefit from IV albumin to prevent kidney failure.

Summary Spontaneous bacterial peritonitis (SBP) is diagnosed by an ascites fluid cell count of ≥ 250 PMNs and a positive ascites fluid culture. Treatment of SBP is IV ceftriaxone 2g daily x 5 days with IV albumin 1.5 g/kg on day one and 1 g/kg on day 3. The concomitant use of albumin with antibiotic therapy is associated with a survival benefit compared with antibiotic therapy alone. Primary prophylaxis of SBP is indicated if the patient has an ascitic fluid total protein (AFTP) < 1, has a history of SBP, or has gastrointestinal bleeding, typically with Bactrim DS daily or ciprofloxacin 500mg daily.